Published Date: 08 Jan 2024
Results from the ZUMA-7 and ZUMA-12 studies are discussed by our panel.
Read Full NewsBacteria are rapidly emerging as a new class of "living medicines" used to kill cancer cells.
Obesity and cancer are two major health challenges of our time, yet the link between them remains only partially understood. New research now highlights a molecular chain of events in estrogen receptor-positive breast cancer, ...
Long-term breast cancer survivors have a higher risk for developing depression, particularly if they have insomnia, according to a study published online Oct. 10 in SLEEPJ.
Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a chemical imaging probe that resists the breakdown of certain compounds in the body, giving doctors a more dependable way ...
1.
Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?
2.
Use of marijuana and alcohol simultaneously is associated with worse outcomes.
3.
For older LBCL patients, Axi-Cel exhibits durable responses and extends overall survival.
4.
Sustained reduction found in prostate cancer mortality with prostate-specific antigen screening
5.
Early cancer detection during pregnancy and the postpartum period may be aided by breast milk examination.
1.
Uncovering the Hidden Symptoms of Parathyroid Cancer in Women
2.
Liquid Biopsy in SCLC: cfDNA Profiling for Diagnosis and Treatment Monitoring
3.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
4.
Living with Shwachman-Diamond Syndrome: A Journey of Hope and Strength
5.
Advancing Medical Oncology: Education, Certification, Clinical Trials, and Evolving Treatment Pathways
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
2.
Current Scenario of Cancer- Q&A Session to Close the Gap
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation